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Summary. Mucus secretions form a protective barrier in
the mucosa of the auditory, gastrointestinal, respiratory,
and urogenital systems, and the conjunctiva in the eyes.
A family of glycoproteins known as gel forming mucins
is the major component of the mucus. Gel-forming
mucins are among the largest and most complex proteins
known. Their polypeptide chains comprise thousands of
amino acid residues organized into different domains
with diverse post-translational modifications, including
O- and N-glycosylation, sulfation, proteolysis, and likely
C-mannosylation. Moreover, these glycoproteins form
disulfide-linked oligomers/multimers with molecular
weights in the millions. Molecular polydispersity in
terms of length, carbohydrate content and composition,
is an invariable feature of purified mucins. This
structural complexity makes it technically very difficult
to study mucin biochemical and physical properties. It is
not surprising, therefore, that our knowledge on mucin
structure, biosynthesis and function still is incomplete.
During the last decade, the use of recombinant mucins
has allowed researchers to study the biochemical
properties of protein domains, peptide motifs and amino
acid residues common to all gel-forming mucins, and to
propose specific roles for them. We review here the
relative impact that these in vitro studies have had for
our current understanding of two of the most important
features of these macromolecules: formation of disulfide
linked oligomers and mucin intragranular packaging. 
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The Gel-forming mucin family of glycoproteins
Five secreted gel-forming mucins, named MUC2,
MUC5AC, MUC5B, MUC6 and MUC19 have been
identified in humans (Dekker et al., 2002; Chen et al.,
2004). Structurally related mucins have been described
in other mammalians, amphibians and fishes and even in
invertebrates. This family of glycoproteins is the major
components of the gel-like mucus that covers epithelial
cells in different organs in all vertebrates, the amphibian
epidermis, and the gills in fishes. Because of their large
sizes, high carbohydrate content, extended solution
structure and polymeric nature, gel-forming mucins
endow mucus secretions with high viscosity and the
necessary chemical diversity to interact, entrap and
transport microorganisms, particles and noxious
chemicals. Moreover, in the gastric mucosa, the
hydrodynamic properties of gel-forming mucins prevent
mucosal damage by hydrochloric acid (Bhaskar et al.,
1992). It is not surprising that deregulation of
mucins/mucus production can have serious health
consequences. For instance, reduction in the synthesis of
intestinal mucins has been associated with predisposition
to colitis (Van der Sluis et al., 2006), and over-
production and accumulation of gel-forming
mucins/mucus is a common feature in the lung of
patients with obstructive lung diseases, including COPD,
cystic fibrosis and asthma (Rose and Voynow, 2006).
Besides lubricating and forming a protecting sheet, gel-
forming mucins have other pivotal roles. Some gastric
mucin oligosaccharides have an antibiotic activity
against Helicobacter pylori, the etiological agent
responsible for gastric ulcer (Kawakubo et al., 2004).
Moreover, gel-forming mucins might interact and retain
important antimicrobial peptides in the airway mucus
(Felgentreff et al., 2006). Furthermore, the major gel-
forming mucin in the colon likely protects against cancer
development in an environment where potentially
carcinogenic products are present (Velcich et al., 2002). 
Common to all mucins is a large, centrally located
and highly glycosylated protein domain, named the
mucin-, O-glycosylation-, or tandem repeat domain,
which comprises most of the mucin polypeptide chains
(Perez-Vilar and Hill, 1999; Dekker et al., 2002) (Fig.
1A). These domains are made of several repeats of a
unique sequence rich in threonine and/or serine residues,
whose hydroxyl groups are in O-glycosidic linkage with
oligosaccharides. O-linked oligosaccharides are very
diverse and provide mucins with the capability to
interact with microorganisms and many compounds (e.
g., Roussel and Lamblin, 2003). The amino acid
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sequence, length and number of repeats vary among
mucins. In all, but MUC6 and likely MUC19, the mucin
domains are interrupted by several copies of a 90-100
amino acid residues cysteine-rich domain, denoted as the
CS (Cys-rich Subdomain)-domain (Desseyn et al., 1997;
Escande et al., 2001). All mucins have signal peptides at
their N-termini followed by three homologous, ~ 320-
400 amino acid residues each, cysteine-rich domains
known as the D1, D2 and the D3 (Disulfide-rich)-
domain (Perez-Vilar and Hill, 1999). A fourth D-domain
(D4) is located after the corresponding mucin domains in
all mucins but MUC6 and MUC19 (Chen et al., 2004,
Rousseau et al., 2004). A potential domain, known as
TIL (Trypsin Inhibitor-Like Cysteine rich domain), has
been recognized within the D-like domains (Lang et al.,
2004). Other protein domains, which include the C (Cys-
rich) and CK (Cystine Knot) domains at the C-termini
(Perez-Vilar and Hill, 1999), are usually under-
glycosylated and rich in cysteine residues. 
Gel-forming mucins are synthesized in and secreted
from specialized cells known as mucous/goblet cells
(Neutra et al., 1984; Specian and Oliver, 1991; Rogers,
2003). These cells are characterized by apically-located
large secretory granules (the mucin granules) where
mucins are accumulated. Mucin biosynthesis and
intracellular trafficking involve three major cellular
compartments: the endoplasmic reticulum, the Golgi
complex and the mucin granules. In the endoplasmic
reticulum mucins are folded, N-glycosylated and likely
C-mannosylated, and form disulfide-linked dimers (e. g.,
Perez-Vilar and Hill, 1999; Asker et al., 1998; Perez-
Vilar et al., 2004). The bulk of O-glycosylation occurs
once the mucin precursors reach the Golgi complex,
where sulfation, formation of mucin disulfide-linked
oligomers/multimers and likely proteolysis also take
place (e. g., Roth et al., 1994; Perez-Vilar et al, 1998;
Perez-Vilar and Hill, 1999; Gold et al., 2002;
Brockhausen, 2003; Lidell et al., 2003a; Lidell and
Hansson, 2006). Inside mucin granules, mucins are
accumulated and stored until proper regulatory signals
triggers granule exocytosis (e. g., Li et al., 2001). 
The study of native mucins. The difficulties
Native gel-forming mucins are difficult to study for
several major reasons. First, a typical human mucin, e.g.,
MUC5B, has around 5,000-6,000 amino acid residues,
of which ~3,000 residues comprise the highly-
glycosylated mucin domain, i.e., Ser/Thr-rich sequences.
O-glycosylated mucins reach an average molecular
weight of more than 1x106 d, which is increased by a
factor of two and up when disulfide-linked species are
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Fig. 1. Multidomain Organization and Covalent
Assembly of Gel-forming Mucins. A.
Schematic representation of the organization
of MUC5AC, a typical gel-forming mucin with
~5,000 amino acid residues. The N-terminal D
domains and the C-terminal CK domains are
involved in the assembly of disulfide-linked
oligomers. The peptide motifs that likely are
involved in the assembly process are shown.
The mucin (M) and unique (U) domains are O-
glycosylated while the CS domains are likely
C-mannosylated. B. Steps in the covalent
assembly of gel-forming mucins. See text for
details.
assembled. At this range of molecular weights, the use
of classical biochemical techniques is mainly limited by
the lack of resolution. Second, the abundance of O-
linked oligosaccharide chains endows mucins with
anomalous behavior in commonly used techniques like
size-exclusion chromatography or SDS-PAGE (e.g.,
Tytgat et al., 1995). Third, molecular polydispersity due
to genetic polymorphism, proteolysis and/or differential
glycosylation is a common feature of gel-forming
mucins (e.g., Vinall et al., 2000; Wickstrom and
Carlstedt, 2001; Veerman et al., 2003). Fourth, mucus
varies from a viscous fluid to a strongly viscoelastic gel,
not readily dispersible in non-denaturing buffers (Bansil
et al., 1995; Bansil and Turner, 2006). Indeed, reduction
of disulfide bonds and extraction in solutions containing
high concentrations of chaotropic agents such as
guanidine are usually required to disperse and get
mucins into solution. These protocols, however, result in
the disappearance of important structural information
and, ultimately, limit the usefulness of these preparations
to perform functional studies (e.g., Bansil et al., 1995;
Raynal et al., 2003). Fifth, when extraction of mucins
under non-denaturing conditions is possible (e.g., from
saliva), mucin preparations are usually “contaminated”
with cellular and bacterial proteins that to some extent
can mask or alter some of the mucin properties. Sixth,
only a few effective inhibitors of O-glycan biosynthesis
are available (e.g., Hang et al., 2004; Patsos et al., 2005).
Altogether the above difficulties have prevented the
mucin field to advance at the same pace than related
fields (e.g., proteoglycans). From the technical point of
view, the use of recombinant mucins overcomes some of
the inconveniences related to the large sizes, extent of
glycosylation, and molecular polydispersity of native
mucins. 
Recombinant mucins as structural model systems.
The assumptions
Any recombinant mucin project first assumes that
the overall properties of native mucins are the sum of the
properties of their protein domains. Accordingly, the
study of an isolated (recombinant) domain should
provide truthful information on its function in the native
mucin. Many of the protein domains present in mucins
are also found in other, functionally diverse, proteins
(Perez-Vilar and Hill, 1999). In a few cases it has been
demonstrated that a single domain has a similar
structural function in two or more proteins. For instance,
the CK-domain found in mucins, TGF-ß1, von
Willebrand factor (VWF) and norrin, among others, is
involved in the formation of disulfide-linked species,
mainly dimers, of the corresponding proteins (e.g., Sun
and Davies, 1995; Perez-Vilar and Hill, 1997, 1999).
However, this is not always the case. For example, the
D-domains in mucins and von-Willebrand factor are
involved in formation of interchain disulfide bonds
while the D-domains in α-tectorins are not (Kevin Legan
et al., 1997; Sadler, 1998; Perez-Vilar, 1999). In other
instances, a protein domain may not have a known
function, even when present in different proteins,
although clues of its function might be obtained from
analysis of its primary sequence. Perhaps the best case of
this type is the CS domain, which has a single conserved
C-mannosylation acceptor site (WXXW) (Spiro, 2002)
that is likely C-mannosylated (Perez-Vilar et al., 2004),
and accordingly could be expected to be involved in
lectin-type interactions. 
The second assumption is also originated from
another technical limitation, i. e., the low number of
physiologically relevant cellular systems to express and
study recombinant mucins. Mucins are synthesized in
and secreted from mucous/goblet cells, a highly-
specialized cell type that is usually found inter-dispersed
among other cell types in epithelial tissues. In
appropriate primary cultures (for instance, human
bronchial epithelial cells; e.g., Perez-Vilar et al., 2003),
mucous cells are scarce and resilient to
transformation/transfection and, hence, are at present of
limited value for expression studies. Indeed, the
biochemistry of recombinant mucins is often studied in
non-native permanent cell lines under the primary
assumption that their posttranslational modifications will
be similar to those of the native mucins. The fact that all
modifications described in mucins (e.g., N- and O-
glycosylation, C-mannosylation, sulfation, disulfide
bond formation, proteolysis, etc) are widespread post-
translational protein modifications not restricted to
certain cell types (Spiro, 2002) lends support to this
assumption. Whether gel-forming mucins have other
specific post-translational modifications is yet to be
determined. Although there is always the possibility that
common post-translational modifications are
differentially regulated in mucous/goblet cells, the
current evidences suggest that this is not the case. For
instance, the CK domain of pMuc19/PSM, the porcine
counterpart of MUC19 (Chen et al., 2004), expressed in
mammalian cells, including non-mucin- and mucin-
producing cell lines, insect or yeast cells, is secreted as a
mixture of unglycosylated and N-glycosylated disulfide-
linked dimers (Perez-Vilar and Hill, 1998a, Perez-Vilar
et al., 2005a; Perez-Vilar, unpublished observations).
However, when the same domain is expressed in
bacteria, only high molecular weight disulfide-linked,
likely unfolded, aggregates are observed (Perez-Vilar,
unpublished observations). These results suggest that the
mechanism operating during the folding and
dimerization of the mucin CK domains is the same
functioning throughout the folding and disulfide bonding
of other secretory proteins in yeast, or different
mammalian cell types. It is reasonable to expect that this
is also the case for other post-translational modifications
in mucins. Conversely, the study of certain properties of
mucins, like those related with mucin sorting,
intragranular packaging or regulated secretion, for
instance, necessarily requires expression of recombinant




Gel-forming mucin covalent assembly
The major steps 
By the early 1980s, it was increasingly clear that gel-
forming mucin polypeptides had non-glycosylated, or
“bare”, protein domains/regions besides the prominent
Ser/Thr-rich glycosylated ones, and that the former were
very likely linked by disulfide bonds to form larger
molecules (e.g., Roberts, 1976; Allen, 1978; Boat and
Cheng, 1980; Silberberg and Meyer, 1982; Carlstedt et
al., 1983; Shogren et al., 1984). Consistent with this
notion, purified mucins observed under the electron
microscope appeared as long linear structures that could
be reduced to smaller subunits on reduction of disulfide
bonds (Carlstedt et al., 1983; Rose et al., 1984). Pulse-
chase studies with mucin-producing cell lines and/or
tissue explants showed that mucin oligomerization likely
begins in the endoplasmic reticulum with the formation
of disulfide-linked dimers and/or trimers and continues
in the Golgi complex (e.g., Dekker et al., 1989; Dekker
and Strous, 1990; Sheehan et al., 1996; Asker et al.,
1998; Van Klinken et al., 1998; Sheehan et al., 2004).
Questions like the degree of oligomerization and the
identification of the specific domains and peptide motifs
involved in the assembly process are out of the reach of
these kinds of studies. These restrictions and the inherent
confusion they create have been the norm over the years
and can be seen in recent manuscripts dealing with
mucin biosynthesis and/or assembly. Nevertheless, the
research direction for overcoming these limitations
became clear once molecular procedures were widely
used by biologists. In their 1990 manuscript on gastric
mucin covalent assembly (Dekker and Strous, 1990),
Dekker and Strous stated that “The nature of the
mechanism of oligomerization and of the signal for
RER-to-Golgi transport can only be elucidated by
cloning and manipulating the gene of this intriguing
molecule”. 
Molecular aspects 
The cloning of frog FIMB1, pMuc19/PSM and
MUC2 cDNA sequences (Probst et al., 1990; Eckhardt et
al., 1991; Gum et al., 1992) not only permitted to design
experiments with recombinant mucins, but revealed that
protein domains in mucins were also present in other
proteins as well. Among these proteins, VWF, an
important blood protein, was also assembled into
disulfide-linked species (Sadler, 1998). Moreover, since
the domains involved in VWF multimerization were
present in mucin polypeptides, it was possible that the
homologous domains mediated mucin oligomerization
(Gum et al., 1992). This notion was initially
corroborated by studies with recombinant domains of
pMuc19/PSM (Perez-Vilar et al., 1996, 1998; Perez-
Vilar and Hill, 1998a, 1998b), the porcine counterpart of
human MUC19 (Perez-Vilar and Hill, 1998c), and later
other animal and human mucins (Bell et al., 1998, 2001,
2003; Xu et al., 2000; Godl et al., 2002; Lidell et al.,
2003b; Perez-Vilar et al., 2005; Lidell and Hansson,
2006). Altogether these studies provided the
experimental basis for the widely-accepted current
paradigm explaining the covalent assembly of gel-
forming mucins, including the likely roles of different
protein domains, peptide motifs and/or specific amino
acid residues (Perez-Vilar and Hill, 1999) (Fig. 1). Most
important, these studies give a reasonable molecular
basis for the studies with native mucins. The assembly is
characterized by four major features that highlight the
complexity associated with the cellular synthesis of large
macromolecules like gel-forming mucins.
First, mucin assembly is a sequential process, which
begins with the formation in the endoplasmic reticulum
of interchain disulfide bonds that link the CK-domains,
and ends in the acidic compartments of the Golgi
complex, where additional disulfide bonds are
established among the N-terminal D-domains. It is
important to note that protein disulfide bonding in the
endoplasmic reticulum is facilitated by the: a) luminal
pH, which is slightly basic; b) ratio between reduced and
oxidized glutathione; and c) presence of thiol/disulfide
oxido/reductases (Wei and Hendershot, 1997; Frand et
al., 2000). In contrast, formation of protein disulfide
bonds in the trans-Golgi compartments is an uncommon
modification that only have been described for mucins
and VWF (Perez-Vilar et al., 1998; Perez-Vilar and Hill,
1998b; Sandler, 1998; Godl et al., 2002), which likely
reflects the fact that: a) acidic pH does not chemically
favor formation of disulfide bonds; and b) no
thiol/disulfide oxido/reductases residing in the trans-
Golgi have been reported. Second, formation of inter-
dimeric disulfide bonds connecting the N-terminal D-
domains requires an acidic pH, as judged by its
sensitivity to agents that increase the intraluminal pH
(Perez-Vilar et al., 1998; Gold et al. 2002). Third, the
CGLC motifs in the mucin D1 and D3 N-terminal
domains are required for inter-dimeric disulfide bonding
(Perez-Vilar and Hill, 1998b). CXXC motifs provide the
critical residues in the catalytic center of thiol/disulfide
oxido/reductases (Noiva, 1994). Fourth, formation of
disulfide bonds among the mucin D-domains takes place
when purified recombinant mucins comprising the N-
terminal D-domains are incubated in slightly acidic
buffers (Perez-Vilar and Boucher, 2004a), consistent
with similar studies with purified VWF (Mayadas and
Wagner, 1989). Altogether these properties support the
notion that mucin oligomerization/multimerization in the
trans-Golgi compartments is a pH-dependent, self-
catalyzed mechanism, in which the CGLC motifs at the
D1 domain provide the necessary enzymatic activity
(Perez-Vilar and Hill, 1998b). Moreover, inside the
endoplasmic reticulum lumen, i.e., at neutral pH, the
CGLC sequence at the D3 domain will prevent
formation of interchain disulfide bonds, as judged by
mutagenesis studies (Perez-Vilar and Hill, 1998b). Thus,
the mucin N-terminal D-domains, and the corresponding
domains in other macromolecules, would have CXXC-
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dependent thiol/disulfide oxido/reductase activities like
protein disulfide isomerases, thioredoxins, etc. In
particular, the D-domains would reduce interchain
disulfide bonds at neutral pH and catalyze their
formation at acidic pH. This notion implies that
formation of disulfide-linked mucin oligomers/
multimers in the endoplasmic reticulum is actively
prevented by goblet/mucous cells, and other cells
specialized in the secretion of CXXC-containing
macromolecules.
There are two reasonable explanations for the
evolutionary emergence and conservation of this
complex mechanism of multimerization. First, in vitro
studies with recombinant pMuc19/PSM suggest that
mucin oligomers assembled in the endoplasmic
reticulum would not be efficiently transported out of this
organelle because of their large sizes (Perez-Vilar and
Hill, 1998b). Second, disulfide-linked multimers, rather
than monomers or dimers, of gel-forming mucins could
be the more biologically active forms (see below), as is
evident by the number of mutations in patients with von
Willebrand disease that alter VWF covalent assembly
mechanism (Sandler, 1998). Hence, in evolutionary
terms, by acquiring the capability to self-reduce/oxidize
disulfide/thiol groups, the N-terminal D-domains in
mucins have made possible an efficient flow of mucin
precursors and the formation of large oligomers/
multimers in a chemically unfavorable, but distal,
compartment. 
Biologic significance 
As judged by the degree of conservancy of the key
peptide motifs, the assembly mechanism of mucins is
extremely well conserved among vertebrates. Moreover,
the length of the mucin strands is critical for mucus
viscoelastic properties, as the degree of entanglement
and the viscosity of random coil polymers like gel-
forming mucins is directly proportional to their lengths
(Doi and See, 1995). In fact, the viscosity of mucin
solutions and mucus can be efficiently diminished with
disulfide reducing agents, or protease digestion (Bansil
et al., 1995). Hence, it is reasonable to presume that the
degree of mucin covalent oligomerization is critical for
the formation of a protective mucus blanket. Recent
studies have shown that cysteine proteases of
Entamoeba histolytica, an intestinal protozoan parasite,
cleave the C-terminal region of MUC2 at two sites
(Lidell et al., 2006). Cutting in one of these sites, which
is located in the D4 domain, predicts the fragmentation
of mucin oligomers into smaller chains, containing only
O-glycosylated polypeptides linked by the N-terminal
side, i.e., lacking continuity through their respective C-
terminal CK-domains. Thus, this parasite appears to
traverse the intestinal mucus protective barrier by
fragmenting the mucin oligomeric strands, which
ultimately reduces the degree of entanglements of the
mucus network and its viscosity. Of course, as any
parasite-host pair relationship, fixation of certain
mutations during evolution can restore the lost function,
as attested by the fact that mMuc2, the mouse
counterpart of MUC2, does not have the cleavage site
(Lidell et al., 2006), which would explains that rodents
are resistant to infections by this protozoan. 
Gel-forming mucin intragranular packaging. The
organization of the granule lumen
Once mucin disulfide-linked oligomers are
assembled in the trans-Golgi compartments, they are
sorted and accumulated into mucin granules. The
molecular and cellular aspects of this process are not
fully understood (Perez-Vilar, 2006). This is a
fascinating research area for biochemists for two main
reasons. First, gel-forming mucins form rather linear
oligomeric strands with contour sizes of 16 µm or more,
which in view of the average diameter of the mucin
granule (~1 µm), suggests intragranular mucins must be
highly condensed. Second, mucins are highly
hydrophilic polyanionic macromolecules, meaning that
any condensation, or accumulation process, must explain
the tendency of mucins to absorb large amounts of water.
That gel-forming mucins are the major component of the
mucin granule matrix (Velcich et al., 2002) suggest that
sorting and matrix assembly are equivalent processes in
contraposition to other regulated secretory granules in
which the secretory product and the granule matrix are
different (Burgoyne and Morgan, 2003). 
The core matrix paradigm
Macromolecules like mucins, which behave in
aqueous solutions like polyanionic random coils
(Verdugo, 1990; Bensil et al., 1995), can be simplified
and reasonable understood by looking into basic
principles of polymer physic theory. This was first
exploited by Verdugo to explain mucin intragranular
packaging on the basis of studies that measured the
degree of expansion of the mucin matrix on exocytosis
(Verdugo, 1984, 1990, 1991; Espinosa et al., 2002;
Kuver et al., 2006). This model suggests that mucin
oligomers form an entangled polymeric network, i. e., a
gel, that at some point during granule formation
undergoes a pH/Ca2+-dependent volume phase
transition. Similar to other regulated secretory granules,
the mucin granules have high intraluminal [Ca2+] and
[H+] (Kuver et al., 2000; Chin et al., 2002). This volume
transition results in the formation of a condensed granule
core matrix comprising entangled mucin strands
stabilized by Ca2+. Secretory proteins (e.g., trefoil
factors, defensins, etc) are entrapped within the
collapsed immobile mucin matrix. Mucins in the matrix
core would have just a hydration shell that would not
allow diffusion of ions and proteins. Additional studies
have shown that the mucin core is likely surrounded by a
fluid with free Ca2+, which can be released from the
granule by diffusion during signal transduction (Nguyen
et al., 1998). Because secretory products entrapped by
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the immobile matrix cannot diffuse they are osmotically
inert and, accordingly, intragranular concentrations of
these proteins are very high without resulting in granule
swelling. 
It is noteworthy to mention here that volume
transitions have been thoroughly characterized in
synthetic polymer gels, and are presumed to occur in all
gels, irrespective of their chemical nature (Li and
Tanaka, 1992). Thus, small changes in temperature,
ionic concentrations, electric field, etc are able to cause a
total collapse (or expansion if the gel is already
collapsed) of the polymer network. In the case of the
granule lumen, increased [Ca2+] and [H+] would be the
triggering factors. These ions would bind to sialic and
sulfate groups in mucin O-glycans, promoting strand
cross-linking and further entanglement (Verdugo, 1990).
Though numerous studies suggest that mucins aggregate
in the presence of high [Ca2+] and/or [H+] (e. g.,
McCullagh et al., 1995; Cao et al., 1999), compelling
evidence showing total mucin collapse is lacking.
Therefore, either intragranular packaging takes place
through another mechanism, or other intragranular
compounds drastically increase the inter-chain affinity of
the highly-hydrophilic mucin oligomers. In this respect,
it has been suggested that intragranular lipids could have
such role (Verdugo, 1990). 
The meshwork matrix paradigm
To better understand the organization of the mucin
granule and to directly test the core matrix paradigm, we
generated a mucous/goblet cell system, named HT29-
SHGMUC5AC/CK cells, consisting of HT29-18N2 cells
(Phillips et al., 1988), a human colon, mucin-producing
adenocarcinoma cell line, permanently expressing a
fusion protein between EGFP (Enhanced Green
Fluorescent Protein) and the CK-domain of MUC5AC
(Perez-Vilar et al., 2005a). When seeded and maintained
in a defined serum-free culture medium, up to ~30% of
the HT29-SHGMU5AC/CK cells in the cultures
differentiated into mucous/goblet cells within two
weeks, as attested by histochemical, immunocyto-
chemical and ultrastructural analyses. The fusion protein
(SHGFP-MUC5AC/CK) co-localized with the native
MUC5AC in the mucin granules where they could be
detected with specific antibodies, although covalent
linkage to the endogenous mucin could not be
demonstrated (Perez-Vilar et al., 2005a). Consistent with
these observations, in living cells the fusion protein
mainly resided in vesicular structures with diameters
(0.5-2.0 mm) similar to the mucin granules observed in
chemically-fixed cells, and that occupied most of the
cytoplasm (Fig. 2)(Perez-Vilar et al., 2005a).
Endoplasmic reticulum, endosome/lysosomes or Golgi
complex fluorescent markers did not co-localized with
the SHGFP-MUC5AC/CK-containing granules in living
or chemically fixed cells (Perez-Vilar et al., 2005b).
Moreover, the fluorescent protein in the granules was
discharge by incubating the cells in the presence of ATP,
a well-established mucin secretagogue, although only a
fraction of the mucous cells and often their granules
were responsive (Perez-Vilar et al., 2006). Further,




Fig. 2. HT29-SHGFP-MUC5AC/CK cells. A. XY confocal images of live differentiated HT29-SHGFP-MUC5AC/CK cells observed with a laser confocal
microscope at 37°C on the stage using the 488 nm laser excitation. Scale bar: 5 µm. B. XY confocal image of a single live mucous cells with numerous
granules containing fluorescent fusion protein. Scale bar: 3 µm. (Reproduced from Perez-Vilar et al., 2005a). 
showing its long term accumulation, as expected for a
regulated secretory product. These results indicated that
these cells are a suitable model system to study goblet
cells and their mucin granules.
The availability of this novel mucous cell model
system made possible a direct experimental testing of the
core matrix paradigm using FRAP (Fluorescent
Recovery After Photobleaching) methods. In a typical
GFP-based FRAP experiment, a subcelular area of
interest is bleached at high laser power and the recovery
of the fluorescence, i. e., the diffusion of the non-
bleached molecules inside the bleached area followed
over time (Lippincott-Schwartz and Patterson, 2003).
Important biophysical information can be derived from
the fluorescence recovery curves regarding the
environment in which the tracer is diffusing, and
indirectly on its organization. In our samples, the
equatorial plane of the largest mucin granules in live
mucous cells were imaged with a laser confocal
microscope and a circular spot with the diameter of the
laser beam was irreversibly bleached (Perez-Vilar et al.,
2005a). The bleached spot and the subsequent recovery
of the fluorescence in the bleached region could be
clearly visualized in all granules analyzed. Most
important, the fluorescent signal recovered in the bleach
area, although not completely (Fig. 3). These results
showed that: a) the fusion protein was able to diffuse,
though very slowly (~0.001 µm2s-1; Perez-Vilar et al.,
2005a); and b) a significant proportion of intragranular
SHGFP-MUC5AC/CK was immobilized during the time
scale of the FRAP analysis. It can be concluded that the
granule lumen comprises, rather than a non-penetrable
mucin matrix core, a matrix meshwork, where proteins
are able to diffuse and to interact with the meshwork
components. The slow diffusion of the protein in the
granule lumen in comparison to its diffusion in the
endoplasmic reticulum lumen or the extracellular
medium (Perez-Vilar et al., 2005a), suggest that the
intragranular matrix is partially condensed though.
Hence, a pH/Ca2+-dependent volume phase transition-
like mechanism of mucin strands to form the meshwork
was possible.
As expected for a matrix meshwork model,
subsequent studies showed that alterations of
intralumenal pH or modifications pertinent to mucins,
including O-glycosylation, sialylation, sulfation or
disulfide-bonding, did alter the protein tracer diffusion
and/or mobilization in the matrix (Perez-Vilar et al.,
2006). The emerging notion from these studies is that the
mucin granule lumen is organized in a pH-dependent,
partially condensed, mucin meshwork embedded in a
fluid phase (Perez-Vilar, 2006). Because reduction of
intragranular protein disulfide bonds did not disorganize
the granule, the matrix meshwork is likely maintained at
acidic pH by inter-strand interactions mediated by Ca2+
and the sialic and sulfate rests in mucin O-glycans
(Perez-Vilar et al., 2006). The degree of mucin sulfation
and sialylation, and also the length of the O-linked
oligosaccharides in the matrix, determine the mobility of
secretory proteins through the meshwork pores.
Secretory proteins can also bind the meshwork, which
has protein- and O-glycan-rich regions. Mucin-type O-
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Fig. 3. FRAP analysis of mucin granules in live mucous cells. A. Representative FRAP analysis involving bleaching of a circular spot in a mucin granule
of a live mucous/goblet cell. Shown are pre-bleaching (left), immediately post-bleaching (center), and 24-s post-bleaching (right) images at two different
magnifications. A low magnification of the cell is also shown (right cell in the inset). Scale bars: 0.5 or 1 µm (inset). B. Averaged (mean ± S.E.)
normalized bleaching/recovery curve for 21 granules in 21 mucous/goblet cells analyzed as described for A. Error bars indicate S.E. (Reproduced from
Perez-Vilar et al., 2005a).
glycans in the latter limit the interactions of secretory
proteins with the protein-rich regions (Perez-Vilar et al.,
2006). The meshwork model clearly points toward a
more sophisticated assembly mechanism during the early
stages of mucin granule biogenesis prior inter-strands
cross-links via Ca2+ are definitely formed. Perhaps the
multi-modular nature of gel-forming mucins might hold
the explanation for such a mechanism. In any case, these
and other important questions, like the recruitment of
membrane and luminal proteins, are currently under
investigation. 
Conclusions and future directions
Molecular biology in general and expression studies
in particular have brought to light the similarities and
differences within the gel-forming mucin family
members. Above all, these studies have shown us a
structural complexity well beyond the simple definition
of mucins as mucoproteins rich in carbohydrates that can
be stained with cationic dyes or the acid-Schiff reagent.
Indeed, nowadays mucin research has wide open
implications for our understanding of the structure
function relationship of large multi-modular proteins, the
topological problems that cells must face to synthesize
and process them, and the biochemical constrains that
prevents the structural diversification of certain protein
domains. Most important, we are starting to provide
direct proof for the roles of mucins in specific diseases
or, at the very least, anticipate their roles with certain
confidence (e.g., Perez-Vilar and Boucher, 2004b).
Although, we have reviewed here two research areas,
mucin assembly and intragranular packaging, in which
recombinant approaches have been particularly fruitful,
similar strategies are beginning to provide significant
and novel information on mucin proteolytical processing
(Xu et al., 2000; Lidell et al., 2003a; Lidell and Hansson,
2006), and mucin O-glycosylation (e.g., Silverman et al.,
2002, 2003; Parry et al., 2005) and its status in
obstructive lung diseases (Leir et al., 2005). Moreover, it
seems reasonable to foresee that in vitro studies in
combination with functional genomic and proteomic
approaches will be the source of the next wave of novel
information on mucins, their mechanisms of secretion
and their roles in health and disease. 
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